Application of artificial intelligence in primary gastrointestinal lymphoma: Opportunities, development potential, and future directions

doi:10.4251/wjgo.116357

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 8

This Article

(0)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article (XML)

Editorial

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Aug 15, 2026; 18(8): 116357
Published online Aug 15, 2026. doi: 10.4251/wjgo.116357

Application of artificial intelligence in primary gastrointestinal lymphoma: Opportunities, development potential, and future directions

Zong-Xian Zhao

Zong-Xian Zhao, Department of Anorectal Surgery, Fuyang People’s Hospital, Fuyang 236000, Anhui Province, China

Author contributions: Zhao ZX designed and wrote the manuscript.

AI contribution statement: Regarding the use of artificial intelligence (AI), we only utilized DeepSeek for text polishing. No AI tools were employed for main text generation, translation, data analysis, or image creation in this study.

Conflict-of-interest statement: The author declare no conflict of interest in publishing the manuscript.

Corresponding author: Zong-Xian Zhao, MD, Department of Anorectal Surgery, Fuyang People’s Hospital, No. 501 Sanqing Road, Yingzhou District, Fuyang 236000, Anhui Province, China. 461901580@qq.com

Received: November 10, 2025
Revised: November 29, 2025
Accepted: January 6, 2026
Published online: August 15, 2026
Processing time: 266 Days and 5.1 Hours

Core Tip

Core Tip: As pointed out by Yang et al, primary gastrointestinal lymphoma (PGIL) remains challenging in diagnosis and treatment, with misdiagnosis and suboptimal therapies persisting. Artificial intelligence (AI) shows great potential in optimizing PGIL’s diagnosis (radiomics, endoscopy, and pathology) and treatment (subtype identification, regimen selection, and complication prediction). However, AI faces hurdles like scarce standardized datasets, poor interpretability, and data security risks. With sustained research, cross-disciplinary collaboration, and standardized efforts, AI is expected to become a standard clinical tool to improve PGIL patient outcomes.